APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drug-Device Combination Products

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Drug-Device Combination Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025194 pages

Choose your research edition.

Industry ResearchDrug-Device Combination Products Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Drug-Device Combination Products Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Drug-Device Combination Products Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drug-Device Combination Products Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Drug-Device Combination Products Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Drug-Device Combination Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Drug-Device Combination Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Drug-Device Combination Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drug-Device Combination Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Drug-Device Combination Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Drug-Device Combination Products include GSK, Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, Boston Scientific, Abbott, Boehringer Ingelheim and Medtronic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Drug-Device Combination Products market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drug-Device Combination Products and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drug-Device Combination Products revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Drug-Device Combination Products market size, projected growth trends, production technologies, key applications, and end-use industries.

Drug-Device Combination Products Segment by Company

GSK

Novo Nordisk

Eli Lilly

AstraZeneca

Sanofi

Boston Scientific

Abbott

Boehringer Ingelheim

Medtronic

Mylan

3M

Hisamitsu

Smith & Nephew

Molnlycke

Teleflex

BD

Lepu Medical

MicroPort

Terumo

B. Braun

Antares Pharma

Drug-Device Combination Products Segment by Type

Drug-Coated Device

Prefilled Drug Delivery Systems

Nebulizer and Inhaler

Transdermal Delivery System

Others

Drug-Device Combination Products Segment by Application

Hospital andClinic

Retail Pharmacies

Other

Drug-Device Combination Products Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug-Device Combination Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drug-Device Combination Products and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug-Device Combination Products.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Drug-Device Combination Products in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drug-Device Combination Products industry.

Chapter 3: Detailed analysis of Drug-Device Combination Products companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Drug-Device Combination Productsrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Drug-Device Combination Products Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Drug-Coated Device Table 3. Key Players of Prefilled Drug Delivery Systems Table 4. Key Players of Nebulizer and Inhaler Table 3. Key Players of Transdermal Delivery System Table 4. Key Players of Others Table 5. Global Drug-Device Combination Products Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 6. Key Players of Hospital andClinic Table 7. Key Players of Retail Pharmacies Table 8. Key Players of Other Table 9. Global Drug-Device Combination Products Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Drug-Device Combination Products Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Drug-Device Combination Products Market Share by Region (2021-2026) Table 12. Global Drug-Device Combination Products Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Drug-Device Combination Products Market Share by Region (2027-2032) Table 14. Drug-Device Combination Products Industry Trends Table 15. Drug-Device Combination Products Industry Drivers Table 16. Drug-Device Combination Products Industry Opportunities and Challenges Table 17. Drug-Device Combination Products Industry Restraints Table 18. Global Drug-Device Combination Products Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Drug-Device Combination Products Revenue Market Share by Company (2021-2026) Table 20. Global Drug-Device Combination Products Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Drug-Device Combination Products Key Company Head Office and Area Served Table 22. Global Drug-Device Combination Products Company, Product Type & Application Table 23. Global Drug-Device Combination Products Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Drug-Device Combination Products by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Drug-Device Combination Products Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Drug-Device Combination Products Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Drug-Device Combination Products Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Drug-Device Combination Products Revenue Market Share by Type (2021-2026) Table 30. Global Drug-Device Combination Products Revenue Market Share by Type (2027-2032) Table 31. Global Drug-Device Combination Products Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Drug-Device Combination Products Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Drug-Device Combination Products Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Drug-Device Combination Products Revenue Market Share by Application (2021-2026) Table 35. Global Drug-Device Combination Products Revenue Market Share by Application (2027-2032) Table 36. GSK Company Information Table 37. GSK Business Overview Table 38. GSK Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. GSK Drug-Device Combination Products Product Portfolio Table 40. GSK Recent Development Table 41. Novo Nordisk Company Information Table 42. Novo Nordisk Business Overview Table 43. Novo Nordisk Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Novo Nordisk Drug-Device Combination Products Product Portfolio Table 45. Novo Nordisk Recent Development Table 46. Eli Lilly Company Information Table 47. Eli Lilly Business Overview Table 48. Eli Lilly Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Eli Lilly Drug-Device Combination Products Product Portfolio Table 50. Eli Lilly Recent Development Table 51. AstraZeneca Company Information Table 52. AstraZeneca Business Overview Table 53. AstraZeneca Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. AstraZeneca Drug-Device Combination Products Product Portfolio Table 55. AstraZeneca Recent Development Table 56. Sanofi Company Information Table 57. Sanofi Business Overview Table 58. Sanofi Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Sanofi Drug-Device Combination Products Product Portfolio Table 60. Sanofi Recent Development Table 61. Boston Scientific Company Information Table 62. Boston Scientific Business Overview Table 63. Boston Scientific Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Boston Scientific Drug-Device Combination Products Product Portfolio Table 65. Boston Scientific Recent Development Table 66. Abbott Company Information Table 67. Abbott Business Overview Table 68. Abbott Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Abbott Drug-Device Combination Products Product Portfolio Table 70. Abbott Recent Development Table 71. Boehringer Ingelheim Company Information Table 72. Boehringer Ingelheim Business Overview Table 73. Boehringer Ingelheim Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Boehringer Ingelheim Drug-Device Combination Products Product Portfolio Table 75. Boehringer Ingelheim Recent Development Table 76. Medtronic Company Information Table 77. Medtronic Business Overview Table 78. Medtronic Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Medtronic Drug-Device Combination Products Product Portfolio Table 80. Medtronic Recent Development Table 81. Mylan Company Information Table 82. Mylan Business Overview Table 83. Mylan Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Mylan Drug-Device Combination Products Product Portfolio Table 85. Mylan Recent Development Table 86. 3M Company Information Table 87. 3M Business Overview Table 88. 3M Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. 3M Drug-Device Combination Products Product Portfolio Table 90. 3M Recent Development Table 91. Hisamitsu Company Information Table 92. Hisamitsu Business Overview Table 93. Hisamitsu Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Hisamitsu Drug-Device Combination Products Product Portfolio Table 95. Hisamitsu Recent Development Table 96. Smith & Nephew Company Information Table 97. Smith & Nephew Business Overview Table 98. Smith & Nephew Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Smith & Nephew Drug-Device Combination Products Product Portfolio Table 100. Smith & Nephew Recent Development Table 101. Molnlycke Company Information Table 102. Molnlycke Business Overview Table 103. Molnlycke Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. Molnlycke Drug-Device Combination Products Product Portfolio Table 105. Molnlycke Recent Development Table 106. Teleflex Company Information Table 107. Teleflex Business Overview Table 108. Teleflex Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. Teleflex Drug-Device Combination Products Product Portfolio Table 110. Teleflex Recent Development Table 111. BD Company Information Table 112. BD Business Overview Table 113. BD Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. BD Drug-Device Combination Products Product Portfolio Table 115. BD Recent Development Table 116. Lepu Medical Company Information Table 117. Lepu Medical Business Overview Table 118. Lepu Medical Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 119. Lepu Medical Drug-Device Combination Products Product Portfolio Table 120. Lepu Medical Recent Development Table 121. MicroPort Company Information Table 122. MicroPort Business Overview Table 123. MicroPort Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 124. MicroPort Drug-Device Combination Products Product Portfolio Table 125. MicroPort Recent Development Table 126. Terumo Company Information Table 127. Terumo Business Overview Table 128. Terumo Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 129. Terumo Drug-Device Combination Products Product Portfolio Table 130. Terumo Recent Development Table 131. B. Braun Company Information Table 132. B. Braun Business Overview Table 133. B. Braun Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 134. B. Braun Drug-Device Combination Products Product Portfolio Table 135. B. Braun Recent Development Table 136. Antares Pharma Company Information Table 137. Antares Pharma Business Overview Table 138. Antares Pharma Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026) Table 139. Antares Pharma Drug-Device Combination Products Product Portfolio Table 140. Antares Pharma Recent Development Table 141. North America Drug-Device Combination Products Market Size by Type (2021-2026) & (US$ Million) Table 142. North America Drug-Device Combination Products Market Size by Type (2027-2032) & (US$ Million) Table 143. North America Drug-Device Combination Products Market Size by Application (2021-2026) & (US$ Million) Table 144. North America Drug-Device Combination Products Market Size by Application (2027-2032) & (US$ Million) Table 145. North America Drug-Device Combination Products Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. North America Drug-Device Combination Products Market Size by Country (2021-2026) Table 147. North America Drug-Device Combination Products Market Size by Country (2027-2032) Table 148. Europe Drug-Device Combination Products Market Size by Type (2021-2026) & (US$ Million) Table 149. Europe Drug-Device Combination Products Market Size by Type (2027-2032) & (US$ Million) Table 150. Europe Drug-Device Combination Products Market Size by Application (2021-2026) & (US$ Million) Table 151. Europe Drug-Device Combination Products Market Size by Application (2027-2032) & (US$ Million) Table 152. Europe Drug-Device Combination Products Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. Europe Drug-Device Combination Products Market Size by Country (2021-2026) Table 154. Europe Drug-Device Combination Products Market Size by Country (2027-2032) Table 155. China Drug-Device Combination Products Market Size by Type (2021-2026) & (US$ Million) Table 156. China Drug-Device Combination Products Market Size by Type (2027-2032) & (US$ Million) Table 157. China Drug-Device Combination Products Market Size by Application (2021-2026) & (US$ Million) Table 158. China Drug-Device Combination Products Market Size by Application (2027-2032) & (US$ Million) Table 159. Asia Drug-Device Combination Products Market Size by Type (2021-2026) & (US$ Million) Table 160. Asia Drug-Device Combination Products Market Size by Type (2027-2032) & (US$ Million) Table 161. Asia Drug-Device Combination Products Market Size by Application (2021-2026) & (US$ Million) Table 162. Asia Drug-Device Combination Products Market Size by Application (2027-2032) & (US$ Million) Table 163. Asia Drug-Device Combination Products Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 164. Asia Drug-Device Combination Products Market Size by Country (2021-2026) Table 165. Asia Drug-Device Combination Products Market Size by Country (2027-2032) Table 166. South America, Middle East & Africa Drug-Device Combination Products Market Size by Type (2021-2026) & (US$ Million) Table 167. South America, Middle East & Africa Drug-Device Combination Products Market Size by Type (2027-2032) & (US$ Million) Table 168. South America, Middle East & Africa Drug-Device Combination Products Market Size by Application (2021-2026) & (US$ Million) Table 169. South America, Middle East & Africa Drug-Device Combination Products Market Size by Application (2027-2032) & (US$ Million) Table 170. South America, Middle East & Africa Drug-Device Combination Products Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. South America, Middle East & Africa Drug-Device Combination Products Market Size by Country (2021-2026) Table 172. South America, Middle East & Africa Drug-Device Combination Products Market Size by Country (2027-2032) Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Drug-Device Combination Products Product Image Figure 2. Global Drug-Device Combination Products Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Drug-Device Combination Products Market Share by Type: 2025 VS 2032 Figure 4. Drug-Coated Device Image Figure 5. Prefilled Drug Delivery Systems Image Figure 6. Nebulizer and Inhaler Image Figure 7. Transdermal Delivery System Image Figure 8. Others Image Figure 9. Global Drug-Device Combination Products Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 10. Global Drug-Device Combination Products Market Share by Application: 2025 VS 2032 Figure 11. Hospital andClinic Image Figure 12. Retail Pharmacies Image Figure 13. Other Image Figure 14. Global Drug-Device Combination Products Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Drug-Device Combination Products Market Size (2021-2032) & (US$ Million) Figure 16. Global Drug-Device Combination Products Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Drug-Device Combination Products Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Drug-Device Combination Products Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Drug-Device Combination Products Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Drug-Device Combination Products Revenue Market Share by Type (2021-2032) Figure 23. Global Drug-Device Combination Products Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Drug-Device Combination Products Revenue Market Share by Application (2021-2032) Figure 25. North America Drug-Device Combination Products Market Size (2021-2032) & (US$ Million) Figure 26. North America Drug-Device Combination Products Market Share by Type (2021-2032) Figure 27. North America Drug-Device Combination Products Market Share by Application (2021-2032) Figure 28. North America Drug-Device Combination Products Market Share by Country (2021-2032) Figure 29. United States Drug-Device Combination Products Market Size (2021-2032) & (US$ Million) Figure 30. Canada Drug-Device Combination Products Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Drug-Device Combination Products Market Size (2021-2032) & (US$ Million) Figure 32. Europe Drug-Device Combination Products Market Size (2021-2032) & (US$ Million) Figure 33. Europe Drug-Device Combination Products Market Share by Type (2021-2032) Figure 34. Europe Drug-Device Combination Products Market Share by Application (2021-2032) Figure 35. Europe Drug-Device Combination Products Market Share by Country (2021-2032) Figure 36. Germany Drug-Device Combination Products Market Size (2021-2032) & (US$ Million) Figure 37. France Drug-Device Combination Products Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Drug-Device Combination Products Market Size (2021-2032) & (US$ Million) Figure 39. Italy Drug-Device Combination Products Market Size (2021-2032) & (US$ Million) Figure 40. Russia Drug-Device Combination Products Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Drug-Device Combination Products Market Size (2021-2032) & (US$ Million) Figure 42. China Drug-Device Combination Products Market Size (2021-2032) & (US$ Million) Figure 43. China Drug-Device Combination Products Market Share by Type (2021-2032) Figure 44. China Drug-Device Combination Products Market Share by Application (2021-2032) Figure 45. Asia Drug-Device Combination Products Market Size (2021-2032) & (US$ Million) Figure 46. Asia Drug-Device Combination Products Market Share by Type (2021-2032) Figure 47. Asia Drug-Device Combination Products Market Share by Application (2021-2032) Figure 48. Asia Drug-Device Combination Products Market Share by Country (2021-2032) Figure 49. Japan Drug-Device Combination Products Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Drug-Device Combination Products Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Drug-Device Combination Products Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Drug-Device Combination Products Market Size (2021-2032) & (US$ Million) Figure 53. India Drug-Device Combination Products Market Size (2021-2032) & (US$ Million) Figure 54. Australia Drug-Device Combination Products Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Drug-Device Combination Products Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Drug-Device Combination Products Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Drug-Device Combination Products Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Drug-Device Combination Products Market Share by Country (2021-2032) Figure 59. Brazil Drug-Device Combination Products Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Drug-Device Combination Products Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Drug-Device Combination Products Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Drug-Device Combination Products Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Drug-Device Combination Products Market Size (2021-2032) & (US$ Million) Figure 64. UAE Drug-Device Combination Products Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Drug-Device Combination Products Market Size (2021-2032) & (US$ Million) Figure 66. Chile Drug-Device Combination Products Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Drug-Coated Device
  • Prefilled Drug Delivery Systems
  • Nebulizer and Inhaler
  • Transdermal Delivery System
  • Others
Applications
  • Hospital andClinic
  • Retail Pharmacies
  • Other
Companies covered
  • GSK
  • Novo Nordisk
  • Eli Lilly
  • AstraZeneca
  • Sanofi
  • Boston Scientific
  • Abbott
  • Boehringer Ingelheim
  • Medtronic
  • Mylan
  • 3M
  • Hisamitsu
  • Smith & Nephew
  • Molnlycke
  • Teleflex
  • BD
  • Lepu Medical
  • MicroPort
  • Terumo
  • B. Braun
  • Antares Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Drug-Device Combination Products Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Drug-Coated Device
  5. 1.2.3 Prefilled Drug Delivery Systems
  6. 1.2.4 Nebulizer and Inhaler
  7. 1.2.5 Transdermal Delivery System
  8. 1.2.6 Others
  9. 1.3 Market Analysis by Application
  10. 1.3.1 Global Drug-Device Combination Products Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital andClinic
  12. 1.3.3 Retail Pharmacies
  13. 1.3.4 Other
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Drug-Device Combination Products Growth Trends by Region
  16. 1.5.1 Global Drug-Device Combination Products Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Drug-Device Combination Products Market Size by Region (2021-2026)
  18. 1.5.3 Drug-Device Combination Products Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Drug-Device Combination Products Market Dynamics
  1. 2.1 Drug-Device Combination Products Industry Trends
  2. 2.2 Drug-Device Combination Products Industry Drivers
  3. 2.3 Drug-Device Combination Products Industry Opportunities and Challenges
  4. 2.4 Drug-Device Combination Products Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Drug-Device Combination Products Revenue by Company (2021-2026)
  2. 3.2 Global Drug-Device Combination Products Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Drug-Device Combination Products Key Company Head office and Area Served
  4. 3.4 Global Drug-Device Combination Products Company, Product Type & Application
  5. 3.5 Global Drug-Device Combination Products Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Drug-Device Combination Products Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Drug-Device Combination Products Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Drug-Device Combination Products Tier 1, Tier 2, and Tier 3
4 Drug-Device Combination Products Market by Type
  1. 4.1 Global Drug-Device Combination Products Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Drug-Device Combination Products Market Size by Type (2021-2032)
  3. 4.3 Global Drug-Device Combination Products Market Size Share by Type (2021-2032)
5 Drug-Device Combination Products Market by Application
  1. 5.1 Global Drug-Device Combination Products Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Drug-Device Combination Products Market Size by Application (2021-2032)
  3. 5.3 Global Drug-Device Combination Products Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 GSK Drug-Device Combination Products Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 Novo Nordisk
  8. 6.2.1 Novo Nordisk Company Information
  9. 6.2.2 Novo Nordisk Business Overview
  10. 6.2.3 Novo Nordisk Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Novo Nordisk Drug-Device Combination Products Product Portfolio
  12. 6.2.5 Novo Nordisk Recent Developments
  13. 6.3 Eli Lilly
  14. 6.3.1 Eli Lilly Company Information
  15. 6.3.2 Eli Lilly Business Overview
  16. 6.3.3 Eli Lilly Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Eli Lilly Drug-Device Combination Products Product Portfolio
  18. 6.3.5 Eli Lilly Recent Developments
  19. 6.4 AstraZeneca
  20. 6.4.1 AstraZeneca Company Information
  21. 6.4.2 AstraZeneca Business Overview
  22. 6.4.3 AstraZeneca Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 AstraZeneca Drug-Device Combination Products Product Portfolio
  24. 6.4.5 AstraZeneca Recent Developments
  25. 6.5 Sanofi
  26. 6.5.1 Sanofi Company Information
  27. 6.5.2 Sanofi Business Overview
  28. 6.5.3 Sanofi Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Sanofi Drug-Device Combination Products Product Portfolio
  30. 6.5.5 Sanofi Recent Developments
  31. 6.6 Boston Scientific
  32. 6.6.1 Boston Scientific Company Information
  33. 6.6.2 Boston Scientific Business Overview
  34. 6.6.3 Boston Scientific Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Boston Scientific Drug-Device Combination Products Product Portfolio
  36. 6.6.5 Boston Scientific Recent Developments
  37. 6.7 Abbott
  38. 6.7.1 Abbott Company Information
  39. 6.7.2 Abbott Business Overview
  40. 6.7.3 Abbott Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Abbott Drug-Device Combination Products Product Portfolio
  42. 6.7.5 Abbott Recent Developments
  43. 6.8 Boehringer Ingelheim
  44. 6.8.1 Boehringer Ingelheim Company Information
  45. 6.8.2 Boehringer Ingelheim Business Overview
  46. 6.8.3 Boehringer Ingelheim Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Boehringer Ingelheim Drug-Device Combination Products Product Portfolio
  48. 6.8.5 Boehringer Ingelheim Recent Developments
  49. 6.9 Medtronic
  50. 6.9.1 Medtronic Company Information
  51. 6.9.2 Medtronic Business Overview
  52. 6.9.3 Medtronic Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Medtronic Drug-Device Combination Products Product Portfolio
  54. 6.9.5 Medtronic Recent Developments
  55. 6.10 Mylan
  56. 6.10.1 Mylan Company Information
  57. 6.10.2 Mylan Business Overview
  58. 6.10.3 Mylan Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Mylan Drug-Device Combination Products Product Portfolio
  60. 6.10.5 Mylan Recent Developments
  61. 6.11 3M
  62. 6.11.1 3M Company Information
  63. 6.11.2 3M Business Overview
  64. 6.11.3 3M Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 3M Drug-Device Combination Products Product Portfolio
  66. 6.11.5 3M Recent Developments
  67. 6.12 Hisamitsu
  68. 6.12.1 Hisamitsu Company Information
  69. 6.12.2 Hisamitsu Business Overview
  70. 6.12.3 Hisamitsu Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Hisamitsu Drug-Device Combination Products Product Portfolio
  72. 6.12.5 Hisamitsu Recent Developments
  73. 6.13 Smith & Nephew
  74. 6.13.1 Smith & Nephew Company Information
  75. 6.13.2 Smith & Nephew Business Overview
  76. 6.13.3 Smith & Nephew Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Smith & Nephew Drug-Device Combination Products Product Portfolio
  78. 6.13.5 Smith & Nephew Recent Developments
  79. 6.14 Molnlycke
  80. 6.14.1 Molnlycke Company Information
  81. 6.14.2 Molnlycke Business Overview
  82. 6.14.3 Molnlycke Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Molnlycke Drug-Device Combination Products Product Portfolio
  84. 6.14.5 Molnlycke Recent Developments
  85. 6.15 Teleflex
  86. 6.15.1 Teleflex Company Information
  87. 6.15.2 Teleflex Business Overview
  88. 6.15.3 Teleflex Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Teleflex Drug-Device Combination Products Product Portfolio
  90. 6.15.5 Teleflex Recent Developments
  91. 6.16 BD
  92. 6.16.1 BD Company Information
  93. 6.16.2 BD Business Overview
  94. 6.16.3 BD Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 BD Drug-Device Combination Products Product Portfolio
  96. 6.16.5 BD Recent Developments
  97. 6.17 Lepu Medical
  98. 6.17.1 Lepu Medical Company Information
  99. 6.17.2 Lepu Medical Business Overview
  100. 6.17.3 Lepu Medical Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Lepu Medical Drug-Device Combination Products Product Portfolio
  102. 6.17.5 Lepu Medical Recent Developments
  103. 6.18 MicroPort
  104. 6.18.1 MicroPort Company Information
  105. 6.18.2 MicroPort Business Overview
  106. 6.18.3 MicroPort Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 MicroPort Drug-Device Combination Products Product Portfolio
  108. 6.18.5 MicroPort Recent Developments
  109. 6.19 Terumo
  110. 6.19.1 Terumo Company Information
  111. 6.19.2 Terumo Business Overview
  112. 6.19.3 Terumo Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 Terumo Drug-Device Combination Products Product Portfolio
  114. 6.19.5 Terumo Recent Developments
  115. 6.20 B. Braun
  116. 6.20.1 B. Braun Company Information
  117. 6.20.2 B. Braun Business Overview
  118. 6.20.3 B. Braun Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  119. 6.20.4 B. Braun Drug-Device Combination Products Product Portfolio
  120. 6.20.5 B. Braun Recent Developments
  121. 6.21 Antares Pharma
  122. 6.21.1 Antares Pharma Company Information
  123. 6.21.2 Antares Pharma Business Overview
  124. 6.21.3 Antares Pharma Drug-Device Combination Products Revenue and Gross Margin (US$ Million) & (2021-2026)
  125. 6.21.4 Antares Pharma Drug-Device Combination Products Product Portfolio
  126. 6.21.5 Antares Pharma Recent Developments
7 North America
  1. 7.1 North America Drug-Device Combination Products Market Size (2021-2032)
  2. 7.2 North America Drug-Device Combination Products Market Size by Type
  3. 7.2.1 North America Drug-Device Combination Products Market Size by Type (2021-2026)
  4. 7.2.2 North America Drug-Device Combination Products Market Size by Type (2027-2032)
  5. 7.2.3 North America Drug-Device Combination Products Market Share by Type (2021-2032)
  6. 7.3 North America Drug-Device Combination Products Market Size by Application
  7. 7.3.1 North America Drug-Device Combination Products Market Size by Application (2021-2026)
  8. 7.3.2 North America Drug-Device Combination Products Market Size by Application (2027-2032)
  9. 7.3.3 North America Drug-Device Combination Products Market Share by Application (2021-2032)
  10. 7.4 North America Drug-Device Combination Products Market Size by Country
  11. 7.4.1 North America Drug-Device Combination Products Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Drug-Device Combination Products Market Size by Country (2021-2026)
  13. 7.4.3 North America Drug-Device Combination Products Market Size by Country (2027-2032)
  14. 7.4.4 North America Drug-Device Combination Products Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Drug-Device Combination Products Market Size (2021-2032)
  2. 8.2 Europe Drug-Device Combination Products Market Size by Type
  3. 8.2.1 Europe Drug-Device Combination Products Market Size by Type (2021-2026)
  4. 8.2.2 Europe Drug-Device Combination Products Market Size by Type (2027-2032)
  5. 8.2.3 Europe Drug-Device Combination Products Market Share by Type (2021-2032)
  6. 8.3 Europe Drug-Device Combination Products Market Size by Application
  7. 8.3.1 Europe Drug-Device Combination Products Market Size by Application (2021-2026)
  8. 8.3.2 Europe Drug-Device Combination Products Market Size by Application (2027-2032)
  9. 8.3.3 Europe Drug-Device Combination Products Market Share by Application (2021-2032)
  10. 8.4 Europe Drug-Device Combination Products Market Size by Country
  11. 8.4.1 Europe Drug-Device Combination Products Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Drug-Device Combination Products Market Size by Country (2021-2026)
  13. 8.4.3 Europe Drug-Device Combination Products Market Size by Country (2027-2032)
  14. 8.4.4 Europe Drug-Device Combination Products Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Drug-Device Combination Products Market Size (2021-2032)
  2. 9.2 China Drug-Device Combination Products Market Size by Type
  3. 9.2.1 China Drug-Device Combination Products Market Size by Type (2021-2026)
  4. 9.2.2 China Drug-Device Combination Products Market Size by Type (2027-2032)
  5. 9.2.3 China Drug-Device Combination Products Market Share by Type (2021-2032)
  6. 9.3 China Drug-Device Combination Products Market Size by Application
  7. 9.3.1 China Drug-Device Combination Products Market Size by Application (2021-2026)
  8. 9.3.2 China Drug-Device Combination Products Market Size by Application (2027-2032)
  9. 9.3.3 China Drug-Device Combination Products Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Drug-Device Combination Products Market Size (2021-2032)
  2. 10.2 Asia Drug-Device Combination Products Market Size by Type
  3. 10.2.1 Asia Drug-Device Combination Products Market Size by Type (2021-2026)
  4. 10.2.2 Asia Drug-Device Combination Products Market Size by Type (2027-2032)
  5. 10.2.3 Asia Drug-Device Combination Products Market Share by Type (2021-2032)
  6. 10.3 Asia Drug-Device Combination Products Market Size by Application
  7. 10.3.1 Asia Drug-Device Combination Products Market Size by Application (2021-2026)
  8. 10.3.2 Asia Drug-Device Combination Products Market Size by Application (2027-2032)
  9. 10.3.3 Asia Drug-Device Combination Products Market Share by Application (2021-2032)
  10. 10.4 Asia Drug-Device Combination Products Market Size by Country
  11. 10.4.1 Asia Drug-Device Combination Products Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Drug-Device Combination Products Market Size by Country (2021-2026)
  13. 10.4.3 Asia Drug-Device Combination Products Market Size by Country (2027-2032)
  14. 10.4.4 Asia Drug-Device Combination Products Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Drug-Device Combination Products Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Drug-Device Combination Products Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Drug-Device Combination Products Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Drug-Device Combination Products Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Drug-Device Combination Products Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Drug-Device Combination Products Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Drug-Device Combination Products Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Drug-Device Combination Products Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Drug-Device Combination Products Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Drug-Device Combination Products Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Drug-Device Combination Products Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Drug-Device Combination Products Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Drug-Device Combination Products Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Drug-Device Combination Products Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst